Mats JM, Prez-Gmez C, Nez de Castro I, Asenjo M, Mrquez J
Although lowering systolic blood pressure to less than 130 mmHg reduces the risk of stroke, it remains unclear whether it reduces the risk of coronary artery disease, cardiovascular mortality or all-cause mortality according to the results from clinical trials of patients with diabetes and hypertension [20, 21]
Although histological reversal of advanced fibrosis remains challenging, GLP-1RAs seem to prevent the progression of fibrosis and may promote the regression of early-stage fibrosis
Moderate side effects of tirzepatide and semaglutide can include: Constipation or diarrhea Upset stomach, nausea, and vomiting Headaches Abdominal pain Fatigue Low blood sugar (hypoglycemia) More severe side effects of tirzepatide and semaglutide may include: Vision changes Pancreatitis Kidney failure Gallbladder issues Allergic reactions Who cannot take Semaglutide